Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Mar;184(1):159-177.
doi: 10.1002/ajmg.c.31773. Epub 2020 Feb 21.

Genetic variants in rheumatic fever and rheumatic heart disease

Affiliations
Meta-Analysis

Genetic variants in rheumatic fever and rheumatic heart disease

Babu Muhamed et al. Am J Med Genet C Semin Med Genet. 2020 Mar.

Abstract

Genetic association studies in rheumatic heart disease (RHD) have the potential to contribute toward our understanding of the pathogenetic mechanism, and may shed light on controversies about RHD etiology. Furthermore, genetic association studies may uncover biomarkers that can be used to identify susceptible individuals, and contribute toward developing vaccine and novel therapeutic targets. Genetic predisposition to rheumatic fever and RHD has been hypothesized by findings from familial studies and observed associations between genes located in the human leukocyte antigens on chromosome 6p21.3 and elsewhere in the genome. We sought to summarize, from published Genetic association studies in RHD, evidence on genetic variants implicated in RHD susceptibility. Using HuGENet™ systematic review methods, we evaluated 66 studies reporting on 42 genes. Existing meta-analyses of candidate gene studies suggest that TGF-β1 [rs1800469], and IL-1β [rs2853550] single nucleotide polymorphisms (SNPs) contribute to susceptibility to RHD, whereas the TNF-α [rs1800629 and rs361525], TGF-β1 [rs1800470 and rs4803457], IL-6 [rs1800795], IL-10 [rs1800896] were not associated with RHD. However, candidate gene studies in RF/RHD are relatively small, thus lacking statistical power to identify reliable and reproducible findings, emphasizing the need for large-scale multicenter studies with different populations.

Keywords: genetics; polymorphisms; rheumatic fever; rheumatic heart disease.

PubMed Disclaimer

Similar articles

Cited by

References

REFERENCES

    1. Abdallah, A. M., Al-Mazroea, A. H., Al-Harbi, W. N., Al-Harbi, N. A., Eldardear, A. E., Almohammadi, Y., & Al-Harbi, K. M. (2016). Impact of MIF gene promoter variations on risk of rheumatic heart disease and its age of onset in Saudi Arabian patients. Frontiers in Immunology, 7, 98. https://doi.org/10.3389/fimmu.2016.00098
    1. Abdallah, A. M., Alnuzha, A., Al-Mazroea, A. H., Eldardear, A. E., AlSamman, A. Y., Almohammadi, Y., & Al-Harbi, K. M. (2016). IL10 promoter polymorphisms are associated with rheumatic heart disease in Saudi Arabian patients. Pediatric Cardiology, 37(1), 99-105. https://doi.org/10.1007/s00246-015-1245-y
    1. Aksoy, R., Duman, T., Keskin, O., & Duzgun, N. (2011). No association of PTPN22 R620W gene polymorphism with rheumatic heart disease and systemic lupus erythematosus. Molecular Biology Reports, 38(8), 5,393-5,396. https://doi.org/10.1007/s11033-011-0692-7
    1. Al-Harbi, K. M., Almuzaini, I. S., Morsy, M. M., Abdelaziz, N. A., Al-Balawi, A. M., & Abdallah, A. M. (2015). Angiotensin-converting enzyme gene insertion/deletion polymorphism in Saudi patients with rheumatic heart disease. Saudi Medical Journal, 36(2), 176-180. https://doi.org/10.15537/smj.2015.2.10267
    1. Atalar, E., Tokgozoglu, S. L., Alikasifoglu, M., Ovunc, K., Aksoyek, S., Kes, S., & Tuncbilek, E. (2003). Angiotensin-converting enzyme genotype predicts valve damage in acute rheumatic fever. The Journal of Heart Valve Disease, 12(1), 7-10 Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed...

Publication types

MeSH terms

LinkOut - more resources